22 related articles for article (PubMed ID: 19112920)
1. [Reversal Effect of Arctigenin on the Drug Resistance in Leukemia K562/A02 Cells and Its Mechanism].
Zou L; Fang Y; He W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):409-415. PubMed ID: 38660844
[TBL] [Abstract][Full Text] [Related]
2. HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells.
Chai W; Ye F; Zeng L; Li Y; Yang L
J Exp Clin Cancer Res; 2019 Jul; 38(1):325. PubMed ID: 31331356
[TBL] [Abstract][Full Text] [Related]
3. HMGB1 regulates erastin-induced ferroptosis via RAS-JNK/p38 signaling in HL-60/NRAS
Ye F; Chai W; Xie M; Yang M; Yu Y; Cao L; Yang L
Am J Cancer Res; 2019; 9(4):730-739. PubMed ID: 31105999
[TBL] [Abstract][Full Text] [Related]
4. Adriamycin resistance-associated prohibitin gene inhibits proliferation of human osteosarcoma MG63 cells by interacting with oncogenes and tumor suppressor genes.
Du MD; He KY; Qin G; Chen J; Li JY
Oncol Lett; 2016 Sep; 12(3):1994-2000. PubMed ID: 27602127
[TBL] [Abstract][Full Text] [Related]
5. The implication and potential applications of high-mobility group box 1 protein in breast cancer.
Sohun M; Shen H
Ann Transl Med; 2016 Jun; 4(11):217. PubMed ID: 27386491
[TBL] [Abstract][Full Text] [Related]
6. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
[TBL] [Abstract][Full Text] [Related]
7. HMGB1 is a therapeutic target for leukemia.
Yu Y; Xie M; Kang R; Livesey KM; Cao L; Tang D
Am J Blood Res; 2012; 2(1):36-43. PubMed ID: 22432086
[TBL] [Abstract][Full Text] [Related]
8. High-mobility group box 1 and cancer.
Tang D; Kang R; Zeh HJ; Lotze MT
Biochim Biophys Acta; 2010; 1799(1-2):131-40. PubMed ID: 20123075
[TBL] [Abstract][Full Text] [Related]
9. [Effect of YB-1 gene knockdown on human leukemia cell line K562/A02].
Xu WL; Zhou LL; Chen QY; Chen C; Fang LL; Fang XJ; Shen HL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Aug; 26(4):400-5. PubMed ID: 20017303
[TBL] [Abstract][Full Text] [Related]
10. [Enhancive effect of HMGB1 gene silence on adriamycin-induced apoptosis in K562/A02 drug resistance leukemia cells].
Xie M; Kang R; Yu Y; Zhu S; He YL; Xu WQ; Tang DL; Cao LZ
Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):549-52. PubMed ID: 19112920
[TBL] [Abstract][Full Text] [Related]
11. [Role of high mobility group box 1 in adriamycin-induced apoptosis in leukemia K562 cells].
Yu Y; Xie M; He YL; Xu WQ; Zhu S; Cao LZ
Ai Zheng; 2008 Sep; 27(9):929-33. PubMed ID: 18799030
[TBL] [Abstract][Full Text] [Related]
12. [Enhancive effect of PLK1 gene silencing on sensitivity of K562/A02 cells to adriamycin].
Liu L; Zhang M; Zou P; Tian L; Liu F
Ai Zheng; 2006 Apr; 25(4):404-8. PubMed ID: 16613670
[TBL] [Abstract][Full Text] [Related]
13. [Role of WAVE1 in drug resistance of K562/A02 leukemia cells].
Kang R; Cao LZ; Yu Y; Hu T; Wang Z; Xu WQ; Xie M
Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):379-82. PubMed ID: 17939402
[TBL] [Abstract][Full Text] [Related]
14. [Reversal of multi-drug resistance in K562/A02 cells by small interference RNA of mdr1 gene].
Peng Z; Xiao ZJ; Wang Y; Liu P; Cai YL; Feng WL; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):5-7. PubMed ID: 14990067
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
